Employment of nanomaterials in polymerase chain reaction: insight into the impacts and putative operating mechanisms of nano-additives in PCR

Meral Yuce*a, Hasan Kurtb, Venkata R. S. S. Mokkapatia and Hikmet Budakab
aSabanci University, Nanotechnology Research and Application Centre, 34956, Istanbul, Turkey. E-mail: meralyuce@sabanciuniv.edu
bSabanci University, Faculty of Engineering and Natural Sciences, 34956, Istanbul, Turkey

Received 23rd June 2014 , Accepted 6th August 2014

First published on 7th August 2014


Abstract

The unique ability to rapidly amplify low copy number DNA has made in vitro Polymerase Chain Reaction one of the most fundamental techniques in modern biology. In order to harness this technique to its full potential, certain obstacles such as nonspecific by-products, low yield and complexity of GC rich and long genomic DNA amplification need to be surmounted. As in vitro PCR does not have any regulatory mechanisms unlike its counterpart in vivo DNA replication machinery, scientists often use a number of additives like glycerol, betaine, dimethyl sulphoxide and formamide in order to achieve the perfection of in vivo systems. In the last two decades nanotechnology has provided excellent solutions to many classical problems in various scientific fields including biotechnology and recently the PCR technique has begun to benefit from this so called “Nano Era”. In this review, the impacts of several nanomaterials on PCR efficiency, specificity and fidelity are described in accordance with the recent literature. Putative interaction mechanisms between nanomaterials and primary PCR components are also addressed in a comprehensive manner.


1. Introduction

In vitro Polymerase Chain Reaction (PCR) was first reported by Kjell Kleppe and 1968 Nobel laureate H. Gobind Khorana1 and further improved by 1993 Nobel laureate Kary Banks Mullis,2 who described the method as a “Classical Eureka!” moment.3 Polymerase Chain Reaction, repeated cycles of in vitro DNA synthesis, has quickly become a fundamental technique in molecular biology, biotechnology and clinical medicine following the discovery of a thermostable DNA polymerase enzyme.4 PCR was well-described as: “The process which comprises treating of separate complementary strands of a target nucleic acid with a molar excess of two primers and extending the primers to form complementary primer extension products which in turn act as templates for synthesizing the desired nucleic acid sequence”.5 PCR technique has been used immensely for a wide variety of applications including mutation detection,6 gene cloning,7 genotyping,8 microarray,9 DNA sequencing,10 fingerprinting,11 paternity testing,12 pathogen detection,13 forensics14 and diagnostics.15

The significance of PCR originates from its ability to amplify trace amounts of DNA or cDNA (complementary DNA) sequences within minutes in a reaction realized in an automated machine.16 A successful PCR reaction ideally generates only one amplification product, which is the target sequence with high specificity and fidelity. However, it is well known that PCR is an error-prone reaction due to its in vitro nature; therefore specificity, fidelity and efficiency of PCR are not always satisfactory even after laborious optimization efforts. These drawbacks originate from the fact that PCR does not have any replication control mechanism unlike its counterpart in vivo DNA replication, which operates exclusive enzymes and proteins for the maximum specificity, such as single stranded DNA binding protein.17 Subsequently, PCR produces target amplicon accompanied by non-specific side products called PCR artifacts.18 The main types of PCR artifacts can be categorized as the ones coming from template DNA sequence as a result of chimerical molecule formation and those originating from the skewed template to product ratio due to different amplification or cloning efficiencies.19–21 There are also DNA sequences which are exceptionally difficult to amplify due to their long and GC-rich nature.22 As a result of the stated complications, enhancement of PCR becomes imperative to meet and exceed the current challenges in experimental and clinical biology. Optimization of critical parameters in PCR, such as magnesium ion concentration, annealing temperature, cycle number, template quality, type and concentration of DNA polymerase enzyme and incorporation of various additives, are found to be vital in order to improve the final product sensitivity and efficiency. Several chemical and biological additives including but not limited to glycerol,23 formamide,24 betaine,25 7-deaza-2′-deoxyguanosine22 and DMSO26 have been included in PCR, moreover, new PCR techniques such as hot start PCR27 and touchdown PCR28 are developed in order to achieve higher efficiency and specificity in the reaction.

With the emergence of nanotechnology in 1980s,27 nanomaterials have gained considerable attention from numerous disciplines owing to their exceptional physical and chemical properties like high thermal conductivity and high surface to volume ratios.28–30 Nanomaterial-assisted PCR, so-called nano PCR,31 is a new area in biotechnology that introduces nanostructured materials into PCR reaction to obtain improved specificity and yield results. To date, gold nanoparticles (AuNPs),32 graphene oxide (GO),33 reduced graphene oxide (rGO),33 quantum dots (QDs),34 upconversion nanoparticles (UCNPs),35 fullerenes (C60),36 carbon nanotubes (CNTs),37 some other metallic nanoparticles38 and nanocomposites39 have been investigated for their capability in PCR enhancement. In this review, recent progress on nanomaterial-assisted PCR is discussed with an emphasis on its advantages/disadvantages. The potential interaction mechanisms between nanomaterials and PCR components are also discussed comprehensively. This review provides useful insight for mechanism studies and future applications of nanomaterials in PCR.

2. Gold nanoparticle assisted polymerase chain reaction

Colloidal AuNPs have been used since ancient times owing to their dynamic colors formed via their special interaction with visible light. Unique properties of AuNPs, such as tunable size and physical dimensions, electronic, optical and catalytic activity, high surface-to-volume ratio, stability, biocompatibility and ease of surface modification have made AuNPs excellent scaffolds for nanobiotechnology. Applications of AuNPs in current medical and biological research includes biodetection,40 biodiagnostics and biosensors,41 drug delivery,42 immunoassay studies,43 photothermolysis of cells,44 bioimaging,45 genomics46 and PCR enhancement.47

The first report of colloidal gold additive in PCR reveals that AuNPs are able to enhance the specificity of PCR product significantly. In order to investigate the phenomenon, Li et al.47 selected an error-prone PCR system with a 283 bp λDNA as template. In the presence of citrate-stabilized AuNPs at low concentrations (0.2–0.8 nM), unprecedented yield and specificity enhancement were observed in the PCR amplification. It was also demonstrated that AuNPs induced a substantial yield improvement without any loss in specificity even at significantly low annealing temperatures (25–40 °C). Within the same year Li et al.48 reported that AuNPs contributed to the final efficiency of real-time PCR as well as conventional PCR. In the study, PCR time was shortened without any loss in the yield, and the reaction sensitivity was improved by 5–10 and 104 fold in conventional and quick PCR systems, respectively. Furthermore, Yang et al.49 proposed that specificity and yield improvements in AuNP-assisted PCR could depend on the type of DNA polymerase used in the reactions. It has been stated that the optimized amount of AuNPs could shift threshold cycle (CT) values of real-time PCR when using increased amounts of wild type Taq DNA polymerase, however, no significant change in CT values was observed for recombinant Taq DNA polymerase. In contrast, Haber et al.50 observed neither efficiency nor specificity enrichment in their AuNP-assisted real-time PCR study of three different DNA sequences. As a result of fluorescent quenching of SYBR Green I by AuNPs, the authors indicated the significance of optimization of real time PCR parameters. On the other hand, Vu et al.51 observed that AuNP-assisted PCR favored shorter sequences rather than longer sequences in their semi-multiplex PCR study. In light of these findings, similar promising applications of AuNP-assisted PCR have been reported for detection of Japanese encephalitis retrovirus,52 genotyping of long-range haplotypes46 and amplification of GC-rich DNA templates.53

Despite substantial research on AuNP assisted PCR the fundamental interaction mechanism of AuNPs within PCR system has not been entirely clarified yet. Initially it has been proposed that AuNPs act in a way similar to single-stranded DNA binding protein, which plays a vital role in the specificity of in vivo DNA replication machinery47 and improve overall heat circulation in PCR solution.48 The latter has been discarded since the optimized concentration of AuNPs was significantly below the reported values which could induce a substantial increase in thermal conductivity.50,51,54,55 Furthermore, it has also been found that excess amount of AuNPs totally inhibit the PCR reaction47 and remarkably, inhibition assays revealed the fact that total surface area of AuNPs was governing the inhibition mechanism rather than the particle size.51,56 Inhibition effect of AuNPs is shown to be reversible in the presence of higher concentrations of DNA polymerase or other proteins like BSA and Thrombin, where both proteins compete with DNA polymerase in order to bind on AuNP surface due to Vroman-like effect.57,58

DNA polymerase enzymes have potential to strongly adsorb on AuNP surface via polar groups in their amino acid structure. Although entire side groups of the protein are not positively charged to assure a complete interaction with the negatively charged citrate-capped AuNPs, the collective binding of functional groups would eventually favor a certain level of adsorption. Since there is no evidence for irreversible adsorption mechanism, the adsorption–desorption kinetics on AuNPs would determine the activity of DNA polymerase within PCR. One would think that AuNPs might decrease the efficiency of PCR due to lowered enzymatic activity, however, interaction of other PCR components with AuNPs could still enable the amplification of PCR product.59 Mi et al.60 reported that AuNPs prevents the activity of Pfu DNA polymerase at low temperatures similar to the effect of Mg2+ in a conventional hot-start PCR, thus, stimulating one pot hot-start effect in routine PCR as shown in Fig. 1. In the same study, Mi et al. also demonstrated that Pfu and AuNP-modulated Pfu gave error rates of 1.16 × 10−6 and 1.10 × 10−6, respectively, which were close to the reported value of 1.30 × 10−6 for Pfu, obtained from a PCR-based forward mutation assay utilizing the well-characterized lacI target gene. In consistent with this result, the error rates of 5 nm AuNP, 10 nm AuNP assisted PCR and the control PCR were found to be 7.28 × 10−6, 26.62 × 10−6 and 5.26 × 10−6, respectively.61 Interaction between Pfu DNA polymerase and AuNPs could be strong enough to reduce overall activity of Pfu DNA polymerase at the annealing step. Consequently, AuNPs can hinder the non-specific amplification by avoiding unsolicited mispriming and primer–dimer formation. Similarly, Mandal et al.62 showed that the denaturation point of Taq DNA polymerase enzyme increased from 73 to 81 °C in the presence of AuNPs, which has resulted in enhanced PCR yield. This enhancement mechanism could be explained by the increase in active enzyme concentration at extension step of PCR.


image file: c4ra06144f-f1.tif
Fig. 1 PCR amplification performance of Pfu (left five lanes) and nano-engineered Pfu (right five lanes) for p53 exon 11 gene (406 bp) and β-globin gene (408 bp). Time scale indicates the incubation of Pfu and Pfu-AuNP complex at 58 °C, M represents molecular weight marker. Reproduced with permission from ref. 60 Copyright © 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Whilst the following studies focused on the theory that AuNPs mostly interact with DNA polymerase and modulate its conformation and function under certain conditions;59,60,62 Vu et al.51 reported that hexadecanethiol-coated AuNPs did not affect PCR specificity or efficiency, which revealed the fact that examination of surface properties, is also essential to comprehend AuNP-assisted PCR mechanism.

Together with DNA polymerase effect, probing the interaction between AuNPs and other PCR components (primers, templates) is essential to understand the AuNP assisted PCR mechanism in detail. On account of their short, single-stranded structures, primers or short DNA templates tend to bind on AuNPs by positioning their negatively-charged phosphate backbone away from negatively-charged citrate-capped AuNPs surface, which forms a dielectric double-layer32,63,64 as presented in Fig. 2. Similar to DNA polymerase–AuNP interaction, DNA–AuNP interaction is also based on adsorption–desorption kinetics. Since the size of primers is smaller than DNA polymerase, their kinetics are not severely restricted at bio–nano interface, however, reactivity of primers is constricted at low temperatures. In this perspective, AuNPs could be generating a useful constraint on primer kinetics by decreasing the active primer concentration at low temperatures, which reduces self-primer interactions during annealing step. It is well-established that once short ssDNA sequences attach on the surface of AuNPs, they display a strong propensity to stay on the AuNP surface unless they interact with a complementary sequence.63,65 This could explain the improved specificity and yield in AuNP-assisted PCR for short templates, in which DNA templates on the gold surface only interact with primers or their complementary sequences, which eventually prevent heteroduplex formation. Examples presented in Table 1 suggest that template DNA sequence, primers, type of DNA polymerase enzyme as well as size and surface modification of AuNPs are all critical for the PCR enhancement. Thus, it is imperative to evaluate all these factors on a case-by-case basis.


image file: c4ra06144f-f2.tif
Fig. 2 Possible formation of electrical double layer around AuNPs upon binding to single-stranded DNA.
Table 1 Effects of AuNPs on Polymerase Chain Reaction
AuNPs Size (nm) Conc. (nM) Impact DNA (bp) Enzyme Mg (mM) Ref.
Citrate-stabilized 10 0.4 Improved specificity and efficiency λ-DNA (283 bp) Ex Taq 47
Citrate-stabilized 13 0.7 Improved efficiency EGFP-I (173 bp), PT4K2B (752 bp), MS1R (1236 bp), BNIP3 (238 bp) Supertherm Taq, YEA Taq 48
Citrate-stabilized 12 ± 2 0.2–1.6 No effect fatA (76 bp), RT73 (108 bp), RT3 (273 bp) Taqman probe 50
Citrate-stabilized 13.2 ± 2.4 1.6 Improved specificity and efficiency JEV E gene Taq 2 × 10−6 52
Citrate-stabilized 10 0.4 Improved specificity and efficiency λ-DNA (283 bp), DENV-4 GoTaq 51
Citrate-stabilized 10 2.09 Improved efficiency λ-DNA (792 bp) Taq 3 49
Citrate-stabilized 10 0.38 No effect λ-DNA (792 bp) rTaq 3 49
Citrate-stabilized 5 1.36 Improved specificity and efficiency pBR322/Pst I (309 bp), p53 exon 11 (406 bp), β-globin (408 bp) Pfu 0.08 60
Citrate-stabilized 5, 10, 20 13, 2.85, 0.63 Inhibition Salmonella enterica ATTC 13311 (119 bp) iTaq 3.5 56
Citrate-stabilized 5 1.36 Improved specificity and efficiency SNP loci Taq, LA Taq 3.5 46
Citrate-stabilized 13 1.36 No effect pM18 T (309 bp) Pfu 59
G5.NH2-modified 1.9–2.6 0.37–0.51 Improved specificity and efficiency λ-DNA (283 bp) Ex Taq 1.5 66
Citrate-stabilized 13 0.05 Improved specificity and efficiency GEN, HBV Taq 1.5 32
Citrate-stabilized 11 2 Improved efficiency GAPDH Taq 1.5 62
Citrate-stabilized 10 0.5, 2.28 Improved specificity and efficiency GNAS1 Pfu, rPfu 53
Citrate-stabilized 10 0.35, 1.14–10 Improved specificity and efficiency GNAS1 Taq, Ex Taq 53
PDDA-modified 1.9–2.6 1.54 × 103 Improved specificity and efficiency λ-DNA (283 bp) Taq 1.5 67


Utilization of AuNPs in PCR has shown significant specificity and efficiency improvement in a number of studies. There are few points to emphasize in order to summarize the overall interactions of AuNPs with the major PCR components; (a) AuNPs enable the use of low annealing temperatures during PCR, which reduces the optimization step (b) AuNPs provide adsorption surfaces for primers and short DNA templates, which help preventing mispriming and primer dimer formation, (c) the denaturation temperature of the DNA polymerase increases in the presence of AuNPs which contributes to the number of active enzymes operating at the extension step of PCR, (d) effect of AuNPs can differ from one assay to another as a result of different binding affinities of nucleobases towards AuNPs. For example, adenine has higher affinity for Au surfaces than thymine. On the other hand, guanine and cytosine show similar but moderate affinities to Au surfaces.68 Consequently, AuNP–biomolecule interactions should be investigated further by giving attention to the size, surface charge and concentration of the nanoparticle, which could be useful to reveal the specific conformational changes of the adsorbed molecules which might prevent their activity.

3. Carbon nanotube assisted polymerase chain reaction

Carbon nanotubes are allotropes of carbon with a cylindrical shape of sp2-hybridized carbon atoms.69 The name CNT is derived from its long, hollow structure with the walls formed by single atom-thick sheets of carbon, called graphene.29 CNTs are constructed with a length-to-diameter ratio of up to 132 000 000[thin space (1/6-em)]:[thin space (1/6-em)]1, which is greater than any other standard material.70 Depending on their size in diameter, CNTs are categorized as single-walled carbon nanotubes (SWCNTs; 0.4–2 nm) and multi-walled carbon nanotubes (MWCNTs; 2–100 nm).71 Characteristic properties of CNTs such as high electrical and thermal conductivity, high aspect ratios, exceptional mechanical strength and rigidity have given rise to their use in a variety of applications including electrochemical energy storage and production,72 field emission,73 biosensor construction,74 atomic force microscopy,75 imaging76 and DNA nanotechnology.77 Among these, the discovery of DNA-assisted dispersion and separation of CNTs has opened up new avenues for CNT-based biotechnology research,78,79 one of which is addition of carbon nanotubes into biochemical reactions like PCR.

First utilization of CNT in PCR has been reported by Cui et al.80 where SWCNTs are promoted as PCR enhancers. According to the findings, the final yield of PCR product increased with the addition of SWCNTs up to 3 μg ml−1, however, the reaction was completely inhibited with increasing concentrations. Noticeably, the authors obtained similar results without including Mg2+ in the reaction, which is an essential cofactor for DNA polymerase enzyme to maintain its activity. Although High Resolution Transmission Electron Microscopy (HRTEM) and X-ray Photoelectron Spectroscopy (XPS) data implied a potential physical interaction between SWCNTs and PCR components, the underlying reason of such interaction might be merely the solvent evaporation effect. Since water has a considerable amount of surface tension energy, the liquid–gas interface can carry particles into a limited space during its evaporation. Eventually, free components of sample would tend to concentrate on the first surface available.81,82 Therefore, interactions at bio-nano interface should be further investigated by the techniques that allow to assess materials in their native environment, such as Circular Dichroism (CD) spectroscopy, In situ Atomic Force Microscopy (AFM) and Nuclear Magnetic Resonance Spectroscopy (NMR).

In another study conducted by Zhang et al.83 improved PCR efficiency and specificity by incorporation of CNTs has been reported where a long 14.3 kb lambda DNA was used as template. After performing PCR containing different types of carbon-based nanomaterials (carbon nanopowder, SWCNTs and MWCNTs with different size and surface properties) at various concentrations (max. 1 mg ml−1) it is found that all the tested nanomaterials increased the efficiency and specificity of PCR with a CNT concentration of approximately 0.8 mg ml−1. To assess the fidelity of the CNT-assisted PCR, Zhang et al.83 evaluated Sanger sequencing data of CNT-free PCR and CNT-assisted PCR (SWCNT and MWCNT). The preliminary results showed no significant drop in DNA replication fidelity in comparison to the conventional PCR. Additionally, Shen et al.61 found the error rates of control PCR, SWCNT and MWCNT assisted PCR as 5.26 × 10−6, 16.25 × 10−6 and 32 × 10−6, respectively, which was better than the error rate of betaine (69 × 10−6). Despite the fact that the current fidelity results are not sufficient enough to prove CNT as a viable PCR additive, the data is still promising for further investigation of CNTs in PCR.

There are a large number of reports proving the exceptional thermal84 and mechanical85 properties of CNTs, however, there is still lack of information on the impact of these parameters in PCR which is already a heat-transfer technique. It has been reported that thermal conductivity of individual SWCNTs (9.8 nm in diameter) measured at room temperature surpasses 2000[thin space (1/6-em)]W mK−1 and increases as its size decreases in diameter.86 Although the thermal conductivity of bulk CNTs is lower than SWCNTs, the minimum thermal conductivity is still significantly higher than pure water (0.6 W mK−1 at 20 °C).87 This information proposes that CNT-containing PCR suspension would have a higher thermal conductivity and thus could provide a better thermal transfer and heat equilibrium in PCR tubes. Based on this assumption, Quaglio et al.88 introduced metallic MWCNTs into poly (dimethyl) siloxane (PDMS/CNTs) to monitor alteration in PCR efficiency originating from only thermal properties of the nanocomposite. In the experiment, nanocomposite is deposited on a chip based PCR system and blocking the surface with Bovine Serum Albumin (BSA) prevented surface effect of CNTs. The results displayed a considerable reduction in total reaction time by 75% demonstrating the direct advantage of the MWCNTs in the nanocomposite. Consistent with that result, Cao et al.89 obtained improved PCR products at varying annealing temperatures between 30–55 °C, in which improvement has also been affected by different surface charges of polyethyleneimine-modified MWCNTs. As presented in Fig. 3, both negatively-charged MWCNTs (acid-treated pristine MWCNTs and succinic anhydride-modified CNT/PEI) and positively charged MWCNTs (CNT/PEI) improved the efficiency and specificity of PCR with optimum concentrations of 2.3 × 10−2 and 6.3 × 10−1 mg ml−1, respectively. Nevertheless, neutral MWCNTs (acetic anhydride modified-CNT/PEI) showed neither improvement nor inhibition under similar conditions. These observations suggest that the mechanism of CNT-assisted PCR cannot be thoroughly explained with improved heat conductivity since other factors such as surface charge and electrostatic interactions between nanomaterial and PCR components also contribute to PCR enhancement. In order to probe the physical interaction between MWCNTs and PCR reagents, major PCR components; primers, template (283 bp) and DNA polymerase (recombinant) are individually incubated with negatively-charged acid-treated pristine MWCNT at a concentration of 12.4 mg ml−1 and then combined with remaining PCR reagents prior to thermal cycling.89 It has been discovered that incubation of primers and DNA polymerase with MWCNTs prior to thermal cycling decreases the efficiency of PCR slightly as a result of restricted interaction of the template with primers and the enzyme. It should be noted that the type of polymerases (recombinant, mutant, Taq, Pfu polymerase), primers, length and sequence of templates and physical properties of CNTs vary from one study to another, so owing to their unique structures they might exhibit different behaviors when they are interacted with CNTs. For instance, in contradiction to previous findings, Yi et al.90 reported that CNTs (SWCNT, SWCNT–COOH, MWCNT and MWCNT–COOH) either reduced or inhibited the PCR reactions where the inhibitory effect increased in the order of CNT-COOH > Pristine CNT and SWCNT > MWCNT. In order to discover the source of inhibition, authors surveyed the interaction between CNTs and wild type Taq DNA polymerase by incubating the enzyme with different types of CNTs at various thermal conditions. The data obtained revealed the adsorption of Taq DNA polymerase onto the CNTs regardless of their surface charges or functional groups. Interestingly, it has been also stated that the adsorbed enzyme maintained its activity during PCR, which was evident with target bands on agarose gel. In agreement with this result, Williams et al.37 reported that the adsorption of Taq DNA polymerase on SWCNT is unlikely to inhibit PCR reaction. Eventually, inhibition of the reaction is anticipated as nanomaterial-induced formation of free radicals. There is however no direct experimental evidence of oxidative stress caused by CNT-derived free radicals,91 on the contrary, MWCNTs are shown to have a significant radical scavenging capacity.92 From a different point of view, if the enzyme were still active after adsorption, the reduced band intensities of the targets would be explained with the adsorption of amplified DNA onto CNTs, which would gradually prevent their visibility on the gel at increasing concentrations. To prove such an adsorption of the amplified DNA, purified PCR products could be subjected to thermal cycle with CNTs at different concentrations and evaluated on a high-resolution gel (for example native polyacrylamide gel) under similar conditions. Additionally, the presence of large CNT bundles and the formation of the new bundles during thermal cycles could be other reasons for such inhibition, which may be eliminated or reduced by advanced probe-sonication and filtration steps.


image file: c4ra06144f-f3.tif
Fig. 3 The effect of different surface charges on CNT-assisted PCR. First lane is marker and last lane is negative control (a) Negatively charged acid-treated pristine MWCNT, from lane 1 to 6, the final concentrations are 0, 15.52, 23.28, 31.04, 38.80, and 46.56 mg l−1, (b) positively charged PEI-modified MWCNT, from lane 1 to 6, the final concentrations are 0, 0.17, 0.22, 0.28, 0.39, and 0.44 mg l−1, (c) neutral CNT/PEI modified with acetic anhydride, from lane 1 to 5, the final concentrations are 0, 6.19, 18.57, 30.95, and 43.34 mg l−1, (d) negatively charged CNT/PEI modified with succinic anhydride, from lane 1 to 6, the final concentrations are 0, 0.54, 0.63, 0.78, 0.82, and 0.86 g l−1, respectively. Reproduced with permission from ref. 89 Copyright © 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

As summarized in Table 2, most of the reports indicate a concentration and surface charge dependent PCR enhancement via CNTs, regardless of DNA template length. The optimum CNT concentration for PCR enhancement could be suggested below 1 mg ml−1 for most of the applications. However, it should be noted that the concentration of the bundled CNTs and CNT aggregates cannot be measured with solution based UV-Visible spectroscopy since they tend to precipitate immediately.93,94 Therefore, the utmost caution should be taken while sonicating the CNT solutions, especially the pristine CNT solutions due to their hydrophobic nature, in order to eliminate big aggregates and the bundles as much as possible. The exceptional experimental data should be also taken into consideration in order to understand the origin of such inhibition, which is important for further CNT-based biological applications like nanotoxicology. For example, a set of reference carbon nanomaterials would be useful to test their influence in PCR, wherein sequence dependency could be investigated by using a randomized oligonucleotide library, likewise, enzyme dependency could be tested by employing a number of different polymerase under equal conditions. Another research on the effect of zeta potentials of CNTs in PCR could be useful to identify the exact functions of surface polarities. Finally, a particular research on the effect of CNT length in DNA amplification should very useful to evaluate the aggregation states of the CNTs during PCR, which could enlighten the roles of well-dispersed individual tubes, bundles or aggregates in PCR.

Table 2 Effects of CNT's on Polymerase Chain Reaction
CNT Size (nm) CNT (mg/ml) Impact DNA (bp) Enzyme Mg (mM) Ref.
SWCNT 2 <3 Increased efficiency 410 Taq 0–1.5 80
SWCNT   0.05–0.8   200 Taq 3 90
SWCNT–COOH <2 Either reduced
MWCNT 10–20 Efficiency or reaction inhibition
MWCNT–COOH    
SWCNTs     Increased efficiency and specificity, unaffected fidelity 14[thin space (1/6-em)]000 Pfu, Taq 2.8 83
MWCNTs 1–2 0.6–1.2
CNT–OH <8 0.8–1.6
CNT–COOH    
Negatively charged, pristine, acid-treated MWCNTs 30–70 2.3 × 10−2 Increased efficiency and specificity 283 Taq 1.5 89
Positively charged polyethyleneimine MWCNTs (CNT/PEI) 30–70 3.9 × 10−4 Increased efficiency and specificity 283 Taq 1.5 89
Negatively charged succinic anhydride CNT/PEI 30–70 6.3 × 10−1 Increased efficiency and specificity 283 Taq 1.5 89
Neutral acetic acid anhydride CNT/PEI 30–70 Slightly increased efficiency 283 Taq 1.5 89
Pristine PEI 4 × 10−5 Increased efficiency and specificity 396 Taq 1.5 39
PDMS/MWCNTs based PCR system 20–70 Thermal conductivity induced reaction time improvement 150 Taq 0.25 88
756
CoMoCAT SWCNT (6,5) 0.8 0.01–1 Slightly increased efficiency 76 Taq 37


4. Graphene oxide and reduced graphene oxide assisted polymerase chain reaction

Graphene oxide (GO) is a unique 2D carbon material which exhibits graphene like properties and can be readily dispersed in water and other organic solvents unlike pristine graphene. GO is obtained from exfoliation of graphite oxide which is produced via well-known Hummers method.95 Treatment of graphite oxide with strong oxidizing agents like sulfuric and nitric acid can decorate graphite flakes with hydroxyl, carboxylic acid and other oxygen rich functional groups. Subsequent high frequency sonication of graphite oxide results in a few layer thick hydrophilic GO flakes. Ease of functionalization,96 unique optical97 and mechanical properties,98 excellent fluorescence quenching ability99 and hydrophilic nature have enabled GO to be used in various biomedical research applications including PCR.100 On the other hand, GO can be transformed into reduced GO (rGO) by using chemical, thermal and electrochemical techniques in which rGO regains considerable amount of sp2-hybridized carbon network structure and semi-metal properties due to the improvement in sheet resistance of several orders of magnitude.101 In addition, removal of oxygen-rich functional groups from the surface, while protecting the side functional groups, retains its solubility to certain extent. Like GO, rGO has also been utilized in a wide range of biological applications.102

Employment of GO in PCR has first been reported by Jia et al.33 who revealed that specific concentrations of GO provided a single specific band of desired product without any artifacts. While concentrations less than 12 μg ml−1 didn't show any improvement in terms of specificity enhancement, the concentrations above 70 μg ml−1 inhibited the PCR reaction completely. The authors stated that the GO concentration in the range of 12–60 μg ml−1 was optimum for enhanced PCR specificity. Interestingly, GO did not show enhancement of the specificity of repeated PCR unlike rGO which enhanced the specificity till 8th round in spite of some non-specific bands accumulated from the previous cycles as presented in Fig. 4. This phenomenon has been attributed to strong electrostatic repulsion between DNA molecules and negatively charged GO compared to the electrostatic repulsion between DNA molecules and rGO, which has less surface negative charge compared to GO. This has been proved by X-ray photoelectron spectroscopy and FTIR. In addition, a π–π stacking between the ring structures of nucleotides and hexagonal cells of rGO has also been revealed.


image file: c4ra06144f-f4.tif
Fig. 4 The effect of rGO in nine rounds of error-prone PCR. The template is a pET-32a plasmid DNA of 300 bp; M: DNA marker; C: no. rGO in reaction; 12: rGO concentration in μg mL−1. Reproduced with permission from ref. 33 Copyright © 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Alternatively, rGO has been tested in another error-prone PCR system with a different template and same effect has been observed with 8 μg ml−1 as an optimal concentration whilst 12 μg ml−1 was found to inhibit the process completely. Similar concentration dependent PCR enhancement studies have also been carried out by Khaliq et al.103 using graphene nanoflakes.

As stated in earlier sections, annealing temperature is an important factor for reliable PCR amplification. In conventional PCR, the annealing temperature is usually chosen between 45–65 °C.104 Using rGO, highly specific target bands were obtained at temperatures as low as 25 °C and further increasing the annealing temperature did not affect the product specificity.33 Even though experimental results showed that both GO and rGO improve the specificity of PCR, rGO provides multiple-round PCR enhancement at lower concentrations in comparison to GO. Combining all the available information about GO/rGO-assisted PCR and some other associated information from the recent literature, it could be possible to interpret the interaction of graphene and derivatives with PCR components as summarized below:

• Interaction with DNA on the large surface area

Since overall negative charge distribution on the surface of GO is significantly higher than rGO, negatively charged phosphate backbone of dsDNA would experience a higher electrostatic repulsion from GO surface compared to rGO surface. On the other hand, ssDNA which has one unpaired phosphate backbone would easily bind on GO surface due to non-specific hydrogen bonding105 as illustrated in Fig. 5. Due to the surface functional groups, GO may induce a kinetic barrier for ssDNA to be released back into the reaction. Unlike GO, rGO contains relatively high sp2-hybridized carbon network, less oxygen containing functional groups and nitrogen containing positively charged functional groups. Since the stimulated kinetic barrier is lower in the case of rGO, rGO may offer more convenient platform for the amplification.
image file: c4ra06144f-f5.tif
Fig. 5 Interaction of ssDNA and dsDNA with graphene derivatives.

• rGO–DNA polymerase interaction via surface charges

rGO, which is negatively charged, forms a positively charged complex by interacting with DNA polymerase. Addition of DNA polymerase to rGO solution changes the zeta potential of rGO forming a much DNA-friendly environment. Jia et al.33 confirmed this phenomenon by further adding BSA in different concentrations to the PCR system which also proves that rGO has a strong interaction with DNA polymerase. Higher concentrations of BSA resulted in non-specific bands, which may be due to the severed interactions between rGO and DNA polymerase.

• Effect of high thermal conductivity

PCR specificity enhancement is also attributed to heat transfer properties of the nano additives.48 The higher the thermal conductivity of the material, the better is the specificity.103 Balandin et al.106 have experimentally obtained the thermal conductivity of graphene as 5300 W mK−1 at room temperature. This extremely high value outperforms all the existing conventional materials which are used and tried for PCR specificity enhancement.

Even though the review is related to the PCR specificity enhancement using nanomaterials, the authors would also like to give an insight in to the direct and indirect effects of using nanomaterials with biomolecules. Our literature study states that nanomaterials enhance PCR efficiency and specificity; nevertheless it is a possibility that these nanomaterials may affect the downstream use of these PCR products. Recently, Liu et al.107 have shown that GO can induce mutagenesis in both in vivo and in vitro. This states that though there is a reduction in non-specific bands through nanomaterial-assisted PCR, the collected data may not be entirely reliable at cellular level. Further studies are needed in this aspect to find the right combination of parameters. One such study the authors would like to suggest is that using a nanomaterial coated/integrated PCR tube rather than mixing the nanomaterial with reagents. This approach could avoid the direct chemical interaction of biomolecules with the nanomaterial and at the same time enhance the PCR specificity as a matter of surface property. This process also can remedy the issue of PCR product separation from nanomaterial suspension. To support this method we would like to cite few examples from the literature on the toxicity of GO and rGO to living cells.108 According to Liu et al.107 GO sheets wrap individual cells from the solution unlike rGO where the cells are trapped. The studies have shown that cell trapping by GO is more non-viable to cells compared to cell trapping by rGO. In cell wrapping the surface of the cells is in direct contact with GO sheets causing membrane stress, which is affecting the chemical mechanisms within the cell. Similarly, the bacterial cell membrane could be damaged by sharp edges of GO flakes upon direct contact.109 On the other hand, studies also show that GO substrates accelerate stem cell differentiation.110 In this aspect the substrates (glass/silicon/silicon dioxide) has been coated with GO and the cells were placed on top of that unlike the above mentioned methods where GO flakes were suspended along with cells in a solution. To conclude, the authors would like to propose using GO/rGO coated PCR tubes rather than suspending GO/rGO along with individual PCR components. Theoretical studies so far form a base for this method though further work has to be carried out in integrating GO/rGO efficiently within the PCR tubes.

5. Quantum dot assisted polymerase chain reaction

Quantum dots (QDs) are semiconductor nanoparticles with dimensions in the range of few nanometers to few microns. Their optical and electrical properties, emerging from the quantum confinement can be tuned by their size and shape. QDs have numerous biological applications in gene technology,111 whole body imaging,112 tumor targeting,113 pathogen and toxicity detection114 and enhancement of PCR.115 The current part of the review focuses on PCR enhancement studies using QDs.

Wang et al.116 reported the first use of QDs for PCR specificity enhancement at different annealing temperatures and different template DNAs. Comparative PCR amplification studies using AuNPs and CdTe QDs suggest that both show similar amplifications except that QDs requires higher concentrations than AuNPs.48,117 Similar to other nanomaterials, QDs increase the specificity up to certain optimum concentrations as higher concentrations inhibit the amplification process. Xun et al.118 reported that the thermal cycling durability and PCR compatibility of QDs can be extended by treating them with PEG 2000. This treatment helps the QDs to extend their fluorescence stability without precipitating during PCR.

Different studies suggested different optimal concentrations of QDs for enhanced PCR, though these concentrations are independent of type of PCR, template length and emission wavelengths. Using QDs, PCR specificity enhancement has been mainly observed with small to medium length DNA fragments rather than longer fragments.116 An interesting phenomenon suggested by Liang et al.115 are the optimization of the PCR process by QDs itself and the authors attributed this phenomenon to the affinity between DNA polymerase and QDs. A similar study which explains the affinity between the QDs and DNA polymerase has been reported by Sang et al.117 In annealing temperature studies using QDs, specific target bands are obtained at temperatures as low as 30 °C (ref. 116) similar to GO and AuNP assisted PCR studies.

Another interesting study would be to know whether the PCR specificity enhancement is due to the surface properties of the QDs or QDs itself. Lu Ma and coworkers34 published the results in which they suggested that the PCR specificity enhancement was due to the QD itself rather than the surface property, which can be altered. In spite of a number of reports on PCR enhancement ability of QDs which is summarized in Table 3. On the other hand, only Sang et al.119 reported a study on the fidelity of QD-assisted quantitative PCR by using Rpsl-based fidelity assay, which is good for measurement for low frequency mutations. According to the results, QDs only slightly introduced more mutations than the blank control, but lower than a frequently used PCR enhancer, betaine. Thus the results were found good enough for most short-length quantitative PCR experiments.

Table 3 Effect of different QDs on Polymerase Chain Reaction
QDs Size (nm) QD [nM] Effect Target (bp) Enzyme Annealing (°C) Ref.
Carboxyl based QDs 2–10 4 Increased specificity 297/530 Taq DNA polymerase 30–45 116
CdTe QDs 4.5 60 Increased specificity 310 Taq DNA polymerase 55 115
CdSe QDs (MAA coated) 4.1/2.5 30 Increased yield & specificity 120 Taq DNA polymerase 25–45 34
CdSe/ZnS QDs 22 30 Thermal cycling durability & PCR compatibility 300/245/400 Ex Taq DNA polymerase 60 118
CdTe QDs 85 Increased yield and decent fidelity in qPCR 120/900 Taq DNA polymerase 56 119


The previous studies related to QD-assisted PCR suggest that QDs cannot increase the efficiency of PCR,115,116 because, theoretically QDs are semi-conductors unlike AuNPs or graphene which are highly conductive, indicating low thermal conductivity. Recently, Sang et al.120 reported that using CdTe QDs the PCR reaction time could be significantly shortened without compromising the efficiency in the PCR which can be considered as an important step in QD-assisted PCR research.

Like other PCR enhancing nanomaterials QDs also increase the specificity of the amplification process. The reason for the specificity enhancement is similar to that described for rGO where the modified surface of the QDs is negatively charged because of the carboxyl groups. Due to electrostatic repulsion, negatively charged dsDNA (with high charge density) tend to repel from QDs121,63 unlike ssDNA which has a lower charge density resulting in QDs binding to ssDNA. Interaction of BSA with QDs has also been confirmed by many researchers which can cause reverse effects on PCR.115,118 Though there hasn't been any direct evidence of the side effects on the QD assisted PCR product, it might be a possibility as long as the QDs are not completely recovered from the PCR product before further analysis.

6. Impacts of other nanomaterials in polymerase chain reaction

Nanomaterial assisted PCR studies are not limited to the above-mentioned nanomaterials. In fact, impacts of several other nanomaterials like metal oxide nanoparticles, noble metal nanoparticles and polymeric nanoparticles have also been studied in parallel as summarized in Table 4.
Table 4 Effects of other nanoparticles on PCR
Nanomaterial Size (nm) [Final] Effect Template Enzyme Mg [mM] Ref.
C60 0.25–0.5 Improved efficiency DNA (60 & 110 bp) Taq 36
C60(OH)20 0.02–0.4 μM Inhibition HTSF gene (7 kbp) Taq 2 122
TiO2 NPs 25 0.4 Improved efficiency Human HMGCR exon 11 (364 bp) Taq 1.5 38
Human CHGA exon 7 (534 bp)
Human HSPA1A pro. (1035 bp)
Mouse HMGCR, cDNA domain b. Exon 9 & 11 (448 bp)
TiO2 NPs 0.6 Improved sensitivity Bacterial aerosols Taq 124
ZnO tetrapods 1 mg ml−1 Improved efficiency pEGFPN1 Taq 1.6 125
Ag NPs 0.9 Improved sensitivity Bacterial aerosols Taq 124
Pt NPs 2 ± 0.8   Reduced reaction duration B-globin (248 bp) Taq+ 3.5 126
P(NVP-co-TrpAMT) micelles 60–90 0.1 μg ml−1 Improved efficiency B-actin (496 bp) Taq 127
G5.NH2 dendrimers 1.35 nM Improved specificity and efficiency λDNA (283 bp) Ex Taq 3.5 128
Branched PEI 0.076 μg ml−1 Improved specificity and efficiency λDNA (283 bp) Ex Taq 1.5 89


The utilization of C60 in PCR has been first reported by Liang et al.36 where water insoluble C60 has been dispersed with the help of poly(vinyl-pyrrolidone) as a biocompatible surfactant. While a significant decrease in the melting temperature of DNA template along with a dramatic improvement in the qPCR efficiency (in the beginning of exponential phase at lower CT values) has been observed upon addition of C60, an inhibition took place at later stages, which was attributed to reduce enzymatic activity. Further experiments and simulation studies with water-soluble C60 derivatives shed a light on the interaction of DNA polymerase with C60 molecules. Shang and coworkers122 reported that 0.4 μM concentration of C60(OH)20 fullerene derivative completely inhibited the activity of Taq polymerase in PCR reaction. Atomistic molecular dynamic (MD) simulations exhibited a clear inclination for hydrogen bonding between C60 (OH)20 molecules and PCR components. In a later study, Govindan et al.123 proposed the inhibition route of Taq polymerase upon interaction with fullerene derivatives, fullerenol and fullerene trimalonic acid. Considering molecular docking and MD simulation results, fullerene derivatives lead a conformational change on Taq polymerase originating from close dynamical contact between thumb and finger domains of the protein. Consequently, new configuration of the enzyme severely affected the proficiency of Taq polymerase to capture DNA.

Titanium dioxide (TiO2) nanoparticles and Zinc oxide (ZnO) nanostructures have also been investigated in PCR studies due to their unique surface chemistry. Khaliq et al.38 reported seven-fold improvement in the PCR efficiency using TiO2 nanoparticles. Optimized concentration of TiO2 (0.4 nM) has been used to amplify different sizes of DNA templates with 46–66% GC content, in which the yield was improved by 2.9–6.9 fold and reaction time was shortened by 50%. Similarly, Xu et al.124 reported optimized concentration of TiO2 as 0.6 nM in their PCR detection of bacterial aerosols. The authors stated that the nanomaterial-assisted PCR method lowered the detection limit of airborne biological contamination down to 40 pg μl−1, which has 500 times enhanced sensitivity than conventional PCR.

Moreover, amine and silica functionalized ZnO tetrapods have also been employed to improve PCR,125 wherein amine-functionalized ZnO tetropods showed higher PCR efficiency compared to silica-functionalized tetrapods and control groups showing no improvement in specificity. Noble metals such as platinum (β-cyclodextrin capped) showed no improvement on PCR efficiency and specificity, however, it provided significant improvement in sensitivity and heat transfer leading to a reduction in reaction period.126 Furthermore, Wang and coworkers129 reported three round enhanced PCR amplification of long DNA templates by incorporating 70 nm silver nanoparticles (AgNPs) into PCR amplification.

A small number of nanostructured polymers have also been engaged in nanomaterial-assisted PCR. Firstly, employment of amphiphilic copolymer poly(NVP-co-TrpAMT) with a micelle size of 60–90 nm has resulted in enhanced PCR amplification of GC-rich β-actin.127 Likewise, generation 4 and 5 poly(amidoamine) (G4 & G5 PAMAM) dendrimers have been demonstrated to be useful in both the efficiency and specificity enhancement of two round error-prone PCR of λ-DNA.128 It has been reported that the presence of amine functional groups at higher ratios lowers the optimal concentration to as low as 1.35 nM, which is 4-fold lower concentration than the ones defined for acetylated and carboxylated dendrimers. Finally, like PAMAM dendrimers, which carry substantial amount of amine groups, branched polyethyleneimine (PEI) polymer also exhibit significant efficiency and specificity improvement at considerably low concentrations (0.076 mg ml−1).89

7. Executive summary and discussion

Nanomaterial-assisted PCR is a novel area of nanobiotechnology that integrates nanomaterials with unique properties into conventional PCR system in order to achieve superior amplification products. In this review, latest developments and progress in the field of nanomaterial-assisted PCR are evaluated with a slight focus on putative interaction mechanisms. The effects of different nanomaterials on the efficiency, specificity and fidelity of the target product are summarized and the putative interaction mechanisms between nanomaterials and key PCR components are discussed in detail.

In nanomaterial-assisted PCR, the fact revolves around conditional PCR enhancement via nanomaterials depending on their concentration, thermal conductivity, electron transfer properties, size and surface modifications. Despite several contradictory reports, key benefits of nanomaterial-assisted PCR are mainly associated with the increase in yield and specificity of the target product along with limited information on PCR fidelity. It is important to note that any indication of compromised fidelity renders other improvements irrelevant, thus, fidelity in nanomaterial-assisted PCR requires dedicated research and careful assessment. Another issue that remains ambiguous is the elimination of nanomaterials from PCR for subsequent applications. For example, AuNPs below 20 nm in diameter would require a considerable g-force and long centrifugation period to precipitate in a solution. Their comparable size to amplicon would render filtering methods ineffective. Similarly, CNTs and graphene derivatives could be incompatible with centrifuge methods due to their similar size and density with DNA amplicon. Although gel purification methods might be one option to remove nanomaterials from the solution it would not be practical for high-throughput applications like cloning or sequencing. But CNTs can be attached onto removable surfaces for effective utilization; for example, amine functionalized CNTs can be covalently attached on carboxyl functionalized magnetic beads via NHS-EDC chemistry. Alternatively, CNT-integrated PCR tubes could be developed and superior thermal conductivities of CNTs can be utilized to construct new thermal cycler blocks. Owing to their tunable properties, it might be possible to produce novel CNTs that bear desired features for PCR enhancement while avoiding inhibiting properties.

As anticipated, each nanomaterial would display a different interaction mechanism in PCR as a consequence of their unique physical and chemical properties. Since mainstream information regarding the interaction system between PCR reagents and nanomaterials has been focused on AuNPs, specific interactions of other nanomaterials proceeding at bio-nano interface have not been understood in detail yet. Nevertheless, the following list of assumptions has been provided by considering the typical properties of nanoparticles (i.e., thermal conductivity, high surface to volume ratio, stability, water solubility), which could shed light on association of the nanomaterials with major PCR components.

• High surface to volume ratio

High surface to volume ratios of nanomaterials provide an excellent environment for adsorption and desorption of PCR components on nanomaterial surface. It has been well-proven in the literature that ssDNA and DNA polymerase enzyme bind on nanomaterial surface via π–π stacking, surface charge facilitated interactions or van der Waals' forces.59,78,90,130,131 It was reported long before that AuNPs-modified with ssDNA can distinguish a perfect complementary strand from a single base mutated sequence,132 which could rationalize the enhanced specificity in nanomaterial-assisted PCR. However, it could be wise to optimize the nanomaterial concentration so that they cannot offer a huge surface where the all reactants concentrate at once and stop reacting.

• Vroman (like) effect

In a complex media where different types of molecules emerge, there will be a dynamic competition among biomolecules to adsorb on the surface of nanomaterials. Most abundant biomolecules (mainly short/small ones) will adsorb on the surface at the earlier stages, however, they will be substituted with biomolecules of lower concentration but with greater affinity (mainly larger biomolecules) over the time, which is a phenomenon called Vroman's effect.57,133 Based on this fact, it is possible to observe a significant change in PCR efficiency upon attachment of DNA polymerase on nanomaterial surface. Depending on the DNA polymerase concentration in the solution, the change in efficiency could be in either way, thus efficiency of nano-assisted PCR could be dependent on the equilibrium kinetics of enzyme adsorption.

• Biomolecule/protein corona

The term Corona refers to the adsorption of different proteins and biomolecules onto the nanoparticle surface over time depending on their size and affinities. The structure and composition of corona depends on the physicochemical aspects of the nanomaterials (size, curvature, surface charges and functional groups), temperature and duration of exposure, thus making corona unique for each nanomaterial.134,135 Even though entropy-driven binding usually does not change the conformation of the protein,136 it has been reported that loss of α-helical content occurs when proteins are adsorbed onto nanomaterials. For example, it has been reported that there is a 10% decrease in the alpha-helix structure of human adult hemoglobin upon binding on CdS nanoparticles via sulfur atoms of cysteine residues.137 In this context, adsorption of DNA polymerase onto the nanomaterial surface might induce a conformational change that might modulate enzyme's activity.62,59

• Surface charge of nanomaterials

Zeta potential is an important parameter to apprehend the nanomaterial surface charge and predicting the long-term stability of the colloidal solutions. Nanomaterials with a zeta potential between −10 and +10 mV are considered as almost neutral, while zeta potentials of greater than +30 mV or less than −30 mV are assumed to be cationic and anionic, respectively.138 Selective adsorption of biomolecules on several nanomaterials has been demonstrated previously and for numerous proteins the mechanisms of binding have been referred to the electrostatic interaction.137,139,140 In light of these facts, it can be hypothesized that negatively charged phosphate backbones of DNA molecules would tend to condense on cationic nano surfaces rather than anionic surfaces, and likewise, kinetics of DNA polymerase would be affected from the zeta potential of the nanomaterial, which would ultimately increase the dynamic interaction between biomolecules and nanomaterials.

Consequently, the exciting interaction of nanomaterials with biomolecules provides researchers unique opportunities to proceed and design nano-based PCR additives that can be incorporated into single reactions, PCR tubes, PCR plates and thermal cyclers, so that the critical PCR complications can be addressed in a shorter, simpler and cost-effective manner that can far surpass current technologies. Nanomaterial-assisted PCR offers several advantages over traditional PCR, such as elimination of time-consuming PCR optimizations, higher efficiency and specificity for difficult GC-rich and long DNA sequences. However, reliability and accuracy of nanomaterial-assisted PCR remains in question considering limited research on the fidelity aspect and possible toxicity imposed by nanomaterials. At this point, a systematic and comprehensive approach should be followed in order to elucidate the fundamental mechanisms of nanomaterial-assisted PCR and address the demands of PCR related applications.

Acknowledgements

This work is supported by The Scientific and Technological Research Council of Turkey (TUBITAK), Grant IDs: 114Z051, 113Z611, and EC-FP7 Marie Curie Fellowships, Grant ID: 0010071779 (Project code: T.A.SN-14-01188).

References

  1. K. Kleppe, E. Ohtsuka, R. Kleppe, I. Molineux and H. G. Khorana, J. Mol. Biol., 1971, 56, 341–361 CrossRef CAS.
  2. K. Mullis, F. Faloona, S. Scharf, R. Saiki, G. Horn and H. Erlich, Cold Spring Harbor Symp. Quant. Biol., 1986, 51(1), 263–273 CrossRef CAS.
  3. K. B. Mullis, Angew. Chem., Int. Ed. Engl., 1994, 33, 1209–1213 CrossRef PubMed.
  4. A. Chien, D. B. Edgar and J. M. Trela, J. Bacteriol., 1976, 127, 1550–1557 CAS.
  5. A. Hadidi, R. Flores, J. Randles, and J. Semancik, Viroids: Properties, Detection, Diseases and their Control, Csiro Publishing, 2003 Search PubMed.
  6. M. Orita, Y. Suzuki, T. Sekiya and K. Hayashi, Genomics, 1989, 5, 874–879 CrossRef CAS.
  7. J. N. Larsen, P. Strøman and H. Ipsen, Mol. Immunol., 1992, 29, 703–711 CrossRef CAS.
  8. J. Cheng, Y. Zhang and Q. Li, Nucleic Acids Res., 2004, 32, e61 CrossRef PubMed.
  9. M. Huber, A. Mündlein, E. Dornstauder, C. Schneeberger, C. B. Tempfer, M. W. Mueller and W. M. Schmidt, Anal. Biochem., 2002, 303, 25–33 CrossRef CAS PubMed.
  10. J. Shendure and H. Ji, Nat. Biotechnol., 2008, 26, 1135–1145 CrossRef CAS PubMed.
  11. J. Welsh and M. McClelland, Nucleic Acids Res., 1990, 18, 7213–7218 CrossRef CAS PubMed.
  12. B. Rerkamnuaychoke, W. Chantratita, U. Jomsawat, J. Thanakitgosate and P. Rojanasunan, J. Med. Assoc. Thailand, 2000, 83(suppl 1), S55–S62 Search PubMed.
  13. O. Lazcka, F. J. Del Campo and F. X. Muñoz, Biosens. Bioelectron., 2007, 22, 1205–1217 CrossRef CAS PubMed.
  14. K. Kasai, Y. Nakamura and R. White, J. Forensic Sci., 1990, 35, 1196–1200 CAS.
  15. S. Yang and R. E. Rothman, Lancet Infect. Dis., 2004, 4, 337–348 CrossRef CAS.
  16. N. Zou, S. Ditty, B. Li and S.-C. Lo, BioTechniques, 2003, 35, 758–760 CAS.
  17. R. R. Meyer and P. S. Laine, Microbiol. Rev., 1990, 54, 342–380 CAS.
  18. C. M. Nagamine, K. Chan and Y. F. Lau, Am. J. Hum. Genet., 1989, 45, 337–339 CAS.
  19. A. M. Dunning, P. Talmud and S. E. Humphries, Nucleic Acids Res., 1988, 16, 10393 CrossRef CAS PubMed.
  20. X. Qiu, L. Wu, H. Huang, P. E. McDonel, A. V. Palumbo, J. M. Tiedje and J. Zhou, Appl. Environ. Microbiol., 2001, 67, 880–887 Search PubMed.
  21. M. F. Polz and C. M. Cavanaugh, Appl. Environ. Microbiol., 1998, 64, 3724–3730 CAS.
  22. U. H. Frey, H. S. Bachmann, J. Peters and W. Siffert, Nat. Protoc., 2008, 3, 1312–1317 CrossRef CAS PubMed.
  23. K. Varadaraj and D. M. Skinner, Gene, 1994, 140, 1–5 CrossRef CAS.
  24. G. Sarkar, S. Kapelner and S. S. Sommer, Nucleic Acids Res., 1990, 18, 7465 CrossRef CAS PubMed.
  25. M. Musso, R. Bocciardi, S. Parodi, R. Ravazzolo and I. Ceccherini, J. Mol. Diagn., 2006, 8, 544–550 CAS.
  26. M. A. Jensen, M. Fukushima and R. W. Davis, PLoS One, 2010, 5, e11024 Search PubMed.
  27. K. E. Drexler, Engines of Creation: The Coming Era of Nanotechnology, Anchor Books, 1986 Search PubMed.
  28. A. E. Nel, L. Mädler, D. Velegol, T. Xia, E. M. V. Hoek, P. Somasundaran, F. Klaessig, V. Castranova and M. Thompson, Nat. Mater., 2009, 8, 543–557 CrossRef CAS PubMed.
  29. A. K. Geim and K. S. Novoselov, Nat. Mater., 2007, 6, 183–191 CrossRef CAS PubMed.
  30. S. Berber, Y. K. Kwon and D. Tománek, Phys. Rev. Lett., 2000, 84, 4613–4616 CrossRef CAS.
  31. Y. C. Lin and H. L. Wu, in Transducers 2007-International Solid-State Sensors, Actuators and Microsystems Conference, IEEE, 2007, pp. 391–394 Search PubMed.
  32. X. Lou and Y. Zhang, ACS Appl. Mater. Interfaces, 2013, 5, 6276–6284 CAS.
  33. J. Jia, L. Sun, N. Hu, G. Huang and J. Weng, Small, 2012, 8, 2011–2015 Search PubMed.
  34. L. Ma, S. He, J. Huang, L. Cao, F. Yang and L. Li, Biochimie, 2009, 91, 969–973 CrossRef CAS PubMed.
  35. S.-H. Hwang, S.-G. Im, S. S. Hah, V. T. Cong, E. J. Lee, Y.-S. Lee, G. K. Lee, D.-H. Lee and S. J. Son, PLoS One, 2013, 8, e73408 CAS.
  36. Y. Liang, F. Luo, Y. Lin, Q. Zhou and G. Jiang, Carbon, 2009, 47, 1457–1465 CrossRef CAS PubMed.
  37. R. M. Williams, S. Nayeem, B. D. Dolash and L. J. Sooter, PLoS One, 2014, 9, e94117 Search PubMed.
  38. R. Abdul Khaliq, P. J. Sonawane, B. K. Sasi, B. S. Sahu, T. Pradeep, S. K. Das and N. R. Mahapatra, Nanotechnology, 2010, 21, 255704 CrossRef CAS PubMed.
  39. W. Tong, X. Cao, S. Wen, R. Guo, M. Shen, J. Wang and X. Shi, Int. J. Nanomed., 2012, 7, 1069–1078 CAS.
  40. P. Alivisatos, Nat. Biotechnol., 2004, 22, 47–52 CrossRef CAS PubMed.
  41. N. L. Rosi and C. A. Mirkin, Chem. Rev., 2005, 105, 1547–1562 CrossRef CAS PubMed.
  42. V. M. Rotello, P. Ghosh, G. Han, M. De and C. K. Kim, Adv. Drug Delivery Rev., 2008, 60, 1307–1315 CrossRef PubMed.
  43. X. Liu, Q. Dai, L. Austin, J. Coutts, G. Knowles, J. Zou, H. Chen and Q. Huo, J. Am. Chem. Soc., 2008, 130, 2780–2782 CrossRef CAS PubMed.
  44. D. Pissuwan, S. M. Valenzuela and M. B. Cortie, Trends Biotechnol., 2006, 24, 62–67 CrossRef CAS PubMed.
  45. U. H. F. Bunz and V. M. Rotello, Angew. Chem., Int. Ed. Engl., 2010, 49, 3268–3279 CrossRef CAS PubMed.
  46. P. Chen, D. Pan, C. Fan, J. Chen, K. Huang, D. Wang, H. Zhang, Y. Li, G. Feng, P. Liang, L. He and Y. Shi, Nat. Nanotechnol., 2011, 6, 639–644 Search PubMed.
  47. H. Li, J. Huang, J. Lv, H. An, X. Zhang, Z. Zhang, C. Fan and J. Hu, Angew. Chem., Int. Ed. Engl., 2005, 44, 5100–5103 CrossRef CAS PubMed.
  48. M. Li, Y. C. Lin, C. C. Wu and H. S. Liu, Nucleic Acids Res., 2005, 33, e184 CrossRef PubMed.
  49. W. Yang, L. Mi, X. Cao, X. Zhang, C. Fan and J. Hu, Nanotechnology, 2008, 19, 255101 CrossRef PubMed.
  50. A. L. Haber, K. R. Griffiths, A. K. Jamting and K. R. Emslie, Anal. Bioanal. Chem., 2008, 392, 887–896 CrossRef CAS PubMed.
  51. B. V. Vu, D. Litvinov and R. C. Willson, Anal. Chem., 2008, 80, 5462–5467 CrossRef CAS PubMed.
  52. S. H. Huang, T. C. Yang, M. H. Tsai, I. S. Tsai, H. C. Lu, P. H. Chuang, L. Wan, Y. J. Lin, C. H. Lai and C. W. Lin, Nanotechnology, 2008, 19, 405101 CrossRef PubMed.
  53. W. Yang, X. Li, J. Sun and Z. Shao, ACS Appl. Mater. Interfaces, 2013, 5, 11520–11524 Search PubMed.
  54. P. Keblinski, S. Phillpot, S. U. Choi and J. Eastman, Int. J. Heat Mass Transfer, 2002, 45, 855–863 CrossRef CAS.
  55. D. Kumar, H. Patel, V. Kumar, T. Sundararajan, T. Pradeep and S. Das, Phys. Rev. Lett., 2004, 93, 144301 CrossRef.
  56. W. Wan and J. T. W. Yeow, Nanotechnology, 2009, 20, 325702 CrossRef PubMed.
  57. L. Vroman, A. L. Adams, G. C. Fischer and P. C. Munoz, Blood, 1980, 55, 156–159 CAS.
  58. M. Slack Steven and A. Horbett Thomas, Proteins at Interfaces II, American Chemical Society, Washington, DC, 1995, vol. 602 Search PubMed.
  59. L. Sun, S. Wang, Z. Zhang, Y. Ma, Y. Lai, J. Weng and Q. Zhang, IET Nanobiotechnol., 2011, 5, 20–24 CrossRef CAS PubMed.
  60. L. Mi, Y. Wen, D. Pan, Y. Wang, C. Fan and J. Hu, Small, 2009, 5, 2597–2600 Search PubMed.
  61. C. Shen, W. Yang, Q. Ji, H. Maki, A. Dong and Z. Zhang, Nanotechnology, 2009, 20, 455103 CrossRef PubMed.
  62. S. Mandal, M. Hossain, T. Muruganandan, G. S. Kumar and K. Chaudhuri, RSC Adv., 2013, 3, 20793–20799 RSC.
  63. H. Li and L. Rothberg, Proc. Natl. Acad. Sci. U. S. A., 2004, 101, 14036–14039 CrossRef CAS PubMed.
  64. E. M. Nelson and L. J. Rothberg, Langmuir, 2011, 27, 1770–1707 CrossRef CAS PubMed.
  65. H. Li and L. J. Rothberg, J. Am. Chem. Soc., 2004, 126, 10958–10961 CrossRef CAS PubMed.
  66. J. Chen, X. Cao, R. Guo, M. Shen, C. Peng, T. Xiao and X. Shi, Analyst, 2012, 137, 223–228 RSC.
  67. L. Yuan and Y. He, Analyst, 2013, 138, 539–545 RSC.
  68. H. Kimura-Suda, D. Y. Petrovykh, M. J. Tarlov and L. J. Whitman, J. Am. Chem. Soc., 2003, 125, 9014–9015 Search PubMed.
  69. W. Yang, K. R. Ratinac, S. P. Ringer, P. Thordarson, J. J. Gooding and F. Braet, Angew. Chem., Int. Ed. Engl., 2010, 49, 2114–2138 CrossRef CAS PubMed.
  70. J. Z. Liao and M. J. Tan, Adv. Mater. Res., 2012, 500, 651–656 CrossRef CAS.
  71. S. Iijima and T. Ichihashi, Nature, 1993, 363, 603–605 CrossRef CAS.
  72. G. Che, B. B. Lakshmi, E. R. Fisher and C. R. Martin, Nature, 1998, 393, 346–349 CrossRef CAS PubMed.
  73. W. A. de Heer, A. Chetelain and D. Ugarte, Science, 1995, 270, 1179–1180 CAS.
  74. C. Staii, A. T. Johnson, M. Chen and A. Gelperin, Nano Lett., 2005, 5, 1774–1778 Search PubMed.
  75. H. Dai, J. H. Hafner, A. G. Rinzler, D. T. Colbert and R. E. Smalley, Nature, 1996, 384, 147–150 CrossRef CAS.
  76. L. Minati, V. Antonini, M. Dalla Serra and G. Speranza, Langmuir, 2012, 28, 15900–15906 CrossRef CAS PubMed.
  77. H. Nie, Z. Yang, S. Huang, Z. Wu, H. Wang, R. Yu and J. Jiang, Small, 2012, 8, 1407–1414 CrossRef CAS PubMed.
  78. M. Zheng, A. Jagota, E. D. Semke, B. A. Diner, R. S. McLean, S. R. Lustig, R. E. Richardson and N. G. Tassi, Nat. Mater., 2003, 2, 338–342 CrossRef CAS PubMed.
  79. C. R. Martin and P. Kohli, Nat. Rev. Drug Discovery, 2003, 2, 29–37 CrossRef CAS PubMed.
  80. D. Cui, F. Tian, Y. Kong, I. Titushikin and H. Gao, Nanotechnology, 2004, 15, 154–157 Search PubMed.
  81. H. R. Marsden, L. Gabrielli and A. Kros, Polym. Chem., 2010, 1, 1512–1518 RSC.
  82. G. M. Whitesides and M. Boncheva, Proc. Natl. Acad. Sci. U. S. A., 2002, 99, 4769–4774 CrossRef CAS PubMed.
  83. Z. Zhang, C. Shen, M. Wang, H. Han and X. Cao, BioTechniques, 2008, 44, 537–545 Search PubMed.
  84. J. Hone, M. Whitney, C. Piskoti and A. Zettl, Phys. Rev. B: Condens. Matter Mater. Phys., 1999, 59, 2514–2516 CrossRef.
  85. A. K. Hüttel, G. A. Steele, B. Witkamp, M. Poot, L. P. Kouwenhoven and H. S. J. van der Zant, Nano Lett., 2009, 9, 2547–2552 CrossRef PubMed.
  86. M. Fujii, X. Zhang, H. Xie, H. Ago, K. Takahashi, T. Ikuta, H. Abe and T. Shimizu, Phys. Rev. Lett., 2005, 95, 65502 CrossRef.
  87. M. L. V. Ramires, C. A. Nieto de Castro, Y. Nagasaka, A. Nagashima, M. J. Assael and W. A. Wakeham, J. Phys. Chem. Ref. Data, 1995, 24, 1377–1381 Search PubMed.
  88. M. Quaglio, S. Bianco, R. Castagna, M. Cocuzza and C. F. Pirri, Microelectron. Eng., 2011, 88, 1860–1863 CrossRef CAS PubMed.
  89. X. Cao, J. Chen, S. Wen, C. Peng, M. Shen and X. Shi, Nanoscale, 2011, 3, 1741–1747 Search PubMed.
  90. C. Yi, C.-C. Fong, W. Chen, S. Qi, C.-H. Tzang, S.-T. Lee and M. Yang, Nanotechnology, 2007, 18, 025102 CrossRef.
  91. S. Kang, M. Herzberg, D. F. Rodrigues and M. Elimelech, Langmuir, 2008, 24, 6409–6413 CrossRef CAS PubMed.
  92. I. Fenoglio, M. Tomatis, D. Lison, J. Muller, A. Fonseca, J. B. Nagy and B. Fubini, Free Radical Biol. Med., 2006, 40, 1227–1233 CrossRef CAS PubMed.
  93. J.-S. Lauret, C. Voisin, G. Cassabois, C. Delalande, P. Roussignol, O. Jost and L. Capes, Phys. Rev. Lett., 2003, 90, 057404 CrossRef.
  94. J. Yu, N. Grossiord, C. E. Koning and J. Loos, Carbon, 2007, 45, 618–623 CrossRef CAS PubMed.
  95. W. S. Hummers and R. E. Offeman, J. Am. Chem. Soc., 1958, 80, 1339 CrossRef CAS.
  96. H. Shen, M. Hu, Z. Yang, C. Wang and L. Zhu, Chin. Sci. Bull., 2013, 50, 2016–2020 CrossRef.
  97. D. Chen, H. Feng and J. Li, Chem. Rev., 2012, 112, 6027–6053 CrossRef CAS PubMed.
  98. L. Liu, J. Zhang, J. Zhao and F. Liu, Nanoscale, 2012, 4, 5910–5916 RSC.
  99. S. Li, A. N. Aphale, I. G. Macwan, P. K. Patra, W. G. Gonzalez, J. Miksovska and R. M. Leblanc, ACS Appl. Mater. Interfaces, 2012, 4, 7069–7075 CAS.
  100. C. Chung, Y. Kim, D. Shin, S.-R. Ryoo, B. H. E. E. Hong and D.-H. Min, Acc. Chem. Res., 2013, 46, 2211–2224 CrossRef CAS PubMed.
  101. C. Mattevi, G. Eda, S. Agnoli, S. Miller, K. A. Mkhoyan, O. Celik, D. Mastrogiovanni, G. Granozzi, E. Garfunkel and M. Chhowalla, Adv. Funct. Mater., 2009, 19, 2577–2583 CrossRef CAS PubMed.
  102. Y. Wang, Z. Li, J. Wang, J. Li and Y. Lin, Trends Biotechnol., 2011, 29, 205–212 CrossRef CAS PubMed.
  103. R. Abdul Khaliq, R. M. Kafafy, H. M. Salleh and W. F. Faris, Nanotechnology, 2012, 23, 455106 CrossRef CAS PubMed.
  104. T. Le, E. H. Ashrafi, N. Paul and E. Hidalgo Ashrafi, BioTechniques, 2009, 47, 972–973 CrossRef CAS.
  105. S. He, B. Song, D. Li, C. Zhu, W. Qi, Y. Wen, L. Wang, S. Song, H. Fang and C. Fan, Adv. Funct. Mater., 2010, 20, 453–459 CrossRef CAS PubMed.
  106. A. A. Balandin, S. Ghosh, W. Bao, I. Calizo, D. Teweldebrhan, F. Miao and C. N. Lau, Nano Lett., 2008, 8, 902–907 CrossRef CAS PubMed.
  107. Y. Liu, Y. Luo, J. Wu, Y. Wang, X. Yang, R. Yang, B. Wang, J. Yang and N. Zhang, Sci. Rep., 2013, 3, 3469 Search PubMed.
  108. S. Liu, T. H. Zeng, M. Hofmann, E. Burcombe, J. Wei, R. Jiang, J. Kong and Y. Chen, ACS Nano, 2011, 5, 6971–6980 CrossRef CAS PubMed.
  109. O. Akhavan and E. Ghaderi, ACS Nano, 2010, 4, 5731–5736 CrossRef CAS PubMed.
  110. T. R. Nayak, H. Andersen, V. S. Makam, C. Khaw, S. Bae, X. Xu, P.-L. R. Ee, J.-H. Ahn, B. H. Hong, G. Pastorin and B. Özyilmaz, ACS Nano, 2011, 5, 4670–4678 CrossRef CAS PubMed.
  111. S. Pathak, S. K. Choi, N. Arnheim and M. E. Thompson, J. Am. Chem. Soc., 2001, 123, 4103–4104 CrossRef CAS.
  112. B. Dubertret, P. Skourides, D. J. Norris, V. Noireaux, A. H. Brivanlou and A. Libchaber, Science, 2002, 298, 1759–1762 CrossRef CAS PubMed.
  113. L. Chen, A. J. Zurita, P. U. Ardelt, R. J. Giordano, W. Arap and R. Pasqualini, Chem. Biol., 2004, 11, 1081–1091 CrossRef CAS PubMed.
  114. L. Y. Lee, S. L. Ong, J. Y. Hu, W. J. Ng, Y. Feng, X. Tan and S. W. Wong, Appl. Environ. Microbiol., 2004, 70, 5732–5736 CrossRef CAS PubMed.
  115. G. Liang, C. Ma, Y. Zhu, S. Li, Y. Shao, Y. Wang and Z. Xiao, Nanoscale Res. Lett., 2010, 6, 51 Search PubMed.
  116. L. Wang, Y. Zhu, Y. Jiang, R. Qiao, S. Zhu, W. Chen and C. Xu, J. Phys. Chem. B, 2009, 113, 7637–7641 CrossRef CAS PubMed.
  117. F. Sang, J. Biomed. Sci. Eng., 2012, 05, 295–301 CrossRef CAS.
  118. Z. Xun, X. Zhao and Y. Guan, Nanotechnology, 2013, 24, 355504 CrossRef CAS PubMed.
  119. F. Sang, Z. Zhang, Z. Xu, X. Ju, H. Wang, S. Zhang and C. Guo, Mol. Biotechnol., 2013, 54, 969–976 CrossRef CAS PubMed.
  120. F. Sang, Y. Yang, H. Zhao, M. Ma and Z. Zhang, J. Exp. Nanosci., 2013, 1–7 CrossRef.
  121. Q. Chou, Nucleic Acids Res., 1992, 20, 4371 CrossRef CAS PubMed.
  122. J. Shang, T. A. Ratnikova, S. Anttalainen, E. Salonen, P. C. Ke and H. T. Knap, Nanotechnology, 2009, 20, 415101 CrossRef PubMed.
  123. P. Nedumpully Govindan, L. Monticelli and E. Salonen, J. Phys. Chem. B, 2012, 116, 10676–10683 CrossRef CAS PubMed.
  124. S. Xu and M. Yao, J. Aerosol Sci., 2013, 65, 1–9 CrossRef CAS PubMed.
  125. L. Nie, L. Gao, X. Yan and T. Wang, Nanotechnology, 2007, 18, 015101 CrossRef.
  126. S. Petralia, T. Barbuzzi and G. Ventimiglia, Mater. Sci. Eng., C, 2012, 32, 848–850 CrossRef CAS PubMed.
  127. L. Zhang, Y. Liang, L. Meng, X. Lu and Y. Liu, Chem. Biodiversity, 2007, 4, 163–174 CAS.
  128. X. Cao, X. Shi, W. Yang, X. Zhang, C. Fan and J. Hu, Analyst, 2009, 134, 87–92 RSC.
  129. Q. Wang, J. Li, X. Cao and Z. Zhang, J. Tianjin Univ., Sci. Technol., 2007, 1–5 Search PubMed.
  130. C. H. Lu, H. H. Yang, C. L. Zhu, X. Chen and G. N. Chen, Angew. Chem., 2009, 121, 4879–4881 CrossRef PubMed.
  131. E. Uysal, M. Yuce and H. Kurt, New Biotechnol., 2014, 31, 175 CrossRef PubMed.
  132. J. J. Storhoff, R. Elghanian, R. C. Mucic, C. A. Mirkin and R. L. Letsinger, J. Am. Chem. Soc., 1998, 120, 1959–1964 CrossRef CAS.
  133. D. Y. Furgeson, M. A. Dobrovolskaia, P. Aggarwal, J. B. Hall, C. B. McLeland, M. A. Dobrovolskaia and S. E. McNeil, Adv. Drug Delivery Rev., 2009, 61, 428–437 CrossRef PubMed.
  134. M. Lundqvist, Nat. Nanotechnol., 2013, 8, 701–702 CrossRef CAS PubMed.
  135. P. del Pino, B. Pelaz, Q. Zhang, P. Maffre, G. U. Nienhaus and W. J. Parak, Mater. Horiz., 2014, 1, 301–313 RSC.
  136. M. Rahman, S. Laurent, N. Tawil, L. Yahia, and M. Mahmoudi, Protein–Nanoparticle Interactions: The Bio-Nano Interface (Google eBook), Springer Science & Business, 2013 Search PubMed.
  137. I. Lynch and K. A. Dawson, Nano Today, 2008, 3, 40–47 CrossRef CAS.
  138. J. D. Clogston and A. K. Patri, Methods Mol. Biol., 2011, 697, 63–70 CAS.
  139. H.-Q. Mao, K. Roy, V. L. Troung-Le, K. A. Janes, K. Y. Lin, Y. Wang, J. T. August and K. W. Leong, J. Controlled Release, 2001, 70, 399–421 CrossRef CAS.
  140. M. N. V. Ravi Kumar, U. Bakowsky and C. M. Lehr, Biomaterials, 2004, 25, 1771–1777 CrossRef CAS PubMed.

This journal is © The Royal Society of Chemistry 2014
Click here to see how this site uses Cookies. View our privacy policy here.